Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 1994 | 2017 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 0.935 | 31 | 0 | 1990 | 2018 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.100 | None | 0.963 | 27 | 2 | 1997 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.100 | None | 0.960 | 25 | 7 | 2000 | 2018 | ||||||||
|
CD22 molecule | 0.556 | 0.615 | 0.80 |
|
disease | 0.100 | None | 1.000 | 25 | 0 | 1990 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1995 | 2017 | |||||||||
|
envoplakin | 0.599 | 0.423 | 5.7E-25 |
|
disease | 0.100 | None | 0.913 | 23 | 0 | 1987 | 2019 | ||||||||
|
opsin 1, short wave sensitive | 0.519 | 0.769 | 2.1E-02 |
|
disease | 0.100 | None | 0.957 | 23 | 0 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1987 | 2019 | ||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.100 | None | 1.000 | 22 | 0 | 1990 | 2019 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1984 | 2009 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.100 | None | 0.952 | 21 | 1 | 1999 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.400 | limited | 1.000 | 20 | 0 | 2005 | 2019 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 1993 | 2019 | |||||||||
|
tripartite motif containing 13 | 0.462 | 0.846 | 0.64 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
CXADR Ig-like cell adhesion molecule | 0.454 | 0.885 | 0.37 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1987 | 2018 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | |||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.100 | None | 0.944 | 18 | 2 | 2002 | 2018 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 0.833 | 18 | 0 | 1994 | 2020 | ||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2016 | 2019 |